Cardinal Capital Management Inc (North Carolina)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.78M Sell
49,670
-14
-0% -$2.1K 0.94% 38
2026
Q1
$7.59M Buy
49,684
+19
+0% +$2.91K 0.98% 35
2025
Q4
$6.85M Buy
49,665
+104
+0.2% +$13.6K 0.91% 38
2025
Q3
$6.36M Buy
49,561
+548
+1% +$66.9K 0.88% 40
2025
Q2
$5.93M Buy
49,013
+1,062
+2% +$120K 0.87% 39
2025
Q1
$5.53M Buy
47,951
+142
+0.3% +$15.1K 0.86% 41
2024
Q4
$4.65M Buy
47,809
+490
+1% +$52.3K 0.73% 48
2024
Q3
$5.44M Buy
47,319
+444
+0.9% +$50.4K 0.85% 43
2024
Q2
$4.99M Buy
46,875
+1,156
+3% +$116K 0.84% 43
2024
Q1
$4.58M Buy
45,719
+3,870
+9% +$397K 0.75% 47
2023
Q4
$4.23M Buy
41,849
+154
+0.4% +$14.9K 0.8% 43
2023
Q3
$4.25M Buy
41,695
+816
+2% +$82.8K 0.86% 41
2023
Q2
$4.13M Sell
40,879
-564
-1% -$56.4K 0.83% 42
2023
Q1
$3.81M Sell
41,443
-100
-0.2% -$8.73K 0.79% 44
2022
Q4
$3.77M Sell
41,543
-297
-0.7% -$25K 0.8% 47
2022
Q3
$3.18M Sell
41,840
-546
-1% -$45.3K 0.75% 48
2022
Q2
$3.58M Buy
42,386
+250
+0.6% +$21.9K 0.82% 47
2022
Q1
$3.7M Buy
42,136
+1,615
+4% +$140K 0.75% 50
2021
Q4
$3.54M Buy
40,521
+169
+0.4% +$14K 0.7% 52
2021
Q3
$3.3M Buy
40,352
+139
+0.3% +$12.5K 0.71% 50
2021
Q2
$3.67M Buy
40,213
+466
+1% +$41.5K 0.77% 48
2021
Q1
$3.4M Buy
39,747
+789
+2% +$70.8K 0.75% 46
2020
Q4
$3.68M Buy
38,958
+810
+2% +$70.8K 0.87% 43
2020
Q3
$3.32M Buy
38,148
+299
+0.8% +$25.9K 0.91% 43
2020
Q2
$3.31M Sell
37,849
-5,503
-13% -$475K 0.95% 39
2020
Q1
$3.57M Sell
43,352
-310
-0.7% -$27.7K 1.18% 35
2019
Q4
$4.13M Sell
43,662
-270
-0.6% -$24.2K 1.07% 42
2019
Q3
$3.82M Buy
43,932
+8
+0% +$718 1.05% 43
2019
Q2
$4.01M Sell
43,924
-5,391
-11% -$456K 1.14% 38
2019
Q1
$4.25M Buy
49,315
+282
+0.6% +$22.6K 1.21% 32
2018
Q4
$3.77M Buy
49,033
+825
+2% +$64.2K 1.24% 33
2018
Q3
$3.72M Buy
48,208
+35
+0.1% +$2.59K 1.05% 41
2018
Q2
$3.26M Buy
48,173
+271
+0.6% +$18.7K 0.99% 42
2018
Q1
$3.47M Buy
47,902
+289
+0.6% +$22K 1.09% 40
2017
Q4
$3.58M Sell
47,613
-70
-0.1% -$5.28K 1.08% 42
2017
Q3
$3.67M Buy
47,683
+4,919
+12% +$371K 1.16% 37
2017
Q2
$3.2M Buy
42,764
+8,058
+23% +$571K 1.06% 42
2017
Q1
$2.31M Buy
34,706
+2,916
+9% +$194K 0.84% 47
2016
Q4
$2.08M Sell
31,790
-5,511
-15% -$357K 0.79% 48
2016
Q3
$2.64M Buy
37,301
+750
+2% +$54.7K 1.04% 44
2016
Q2
$2.7M Buy
36,551
+1,124
+3% +$77.7K 1.1% 41
2016
Q1
$2.3M Buy
35,427
+6,229
+21% +$424K 0.97% 46
2015
Q4
$2.25M Sell
29,198
-1,002
-3% -$79.6K 1.01% 45
2015
Q3
$2.49M Buy
30,200
+388
+1% +$34.5K 1.16% 42
2015
Q2
$2.63M Buy
29,812
+3,563
+14% +$327K 1.15% 43
2015
Q1
$2.32M Buy
26,249
+2,079
+9% +$184K 0.98% 46
2014
Q4
$2.01M Buy
24,170
+1,406
+6% +$117K 0.92% 48
2014
Q3
$1.92M Buy
22,764
+1,740
+8% +$141K 0.91% 47
2014
Q2
$1.71M Sell
21,024
-6,187
-23% -$487K 0.85% 47
2014
Q1
$2.07M Buy
27,211
+1,482
+6% +$108K 1.07% 45
2013
Q4
$1.85M Buy
25,729
+102
+0.4% +$7.09K 0.95% 46
2013
Q3
$1.76M Sell
25,627
-189
-0.7% -$12.5K 1% 45
2013
Q2
$1.64M Buy
+25,816
New +$1.68M 0.97% 46

Other funds holding NVS

Cardinal Capital Management Inc (North Carolina)'s NVS Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) reduced its Novartis (NVS) stake by 0.03% in Q2 2026, selling an estimated $2.1K and leaving 49,670 shares worth $7.78M. The position accounts for 0.94% of the portfolio, ranked #38.

Cardinal Capital Management Inc (North Carolina) first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 1,027 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 49,670 shares of Novartis worth $7.78M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) sold 14 Novartis shares in Q2 2026, an estimated $2.1K.
  • Novartis made up 0.94% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #38 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • 1,027 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.